Biotronics3D, London cancer research center to develop MRI software

Justine Varieur Cadet | July 24, 2009 | Health Exec | Precision Medicine

Biotronics3D has worked with the Institute of Cancer Research (ICR) to develop and launch new software, 3D Net Perfusion, designed to improve the accuracy of MRI scan analysis.

The 3D Net Perfusion software extracts data from images of tumors and transforms it into usable information, according to the London-based company. It develops a new method of visualizing and measuring the blood supply to cancers, which feeds tumor growth.

The software is the result of trials at the ICR, and is currently used in 10 research centers. The company said that the ICR scientists continue to work with Biotronics3D software developers to further enhance the product.

Justine Varieur Cadet

Around the web

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

AI in Healthcare

4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Biotronics3D, London cancer research center to develop MRI software

Related Content

Around the web